These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 24067262

  • 1. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
    Polyzos SA, Kountouras J, Papatheodorou A, Katsiki E, Patsiaoura K, Zafeiriadou E, Papadopoulou E, Zavos C, Terpos E.
    Ann Hepatol; 2013; 12(5):749-57. PubMed ID: 24067262
    [Abstract] [Full Text] [Related]

  • 2. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [Abstract] [Full Text] [Related]

  • 3. Serum homocysteine levels in patients with nonalcoholic fatty liver disease.
    Polyzos SA, Kountouras J, Patsiaoura K, Katsiki E, Zafeiriadou E, Deretzi G, Zavos C, Gavalas E, Katsinelos P, Mane V, Slavakis A.
    Ann Hepatol; 2012 Feb; 11(1):68-76. PubMed ID: 22166563
    [Abstract] [Full Text] [Related]

  • 4. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
    Genc H, Dogru T, Kara M, Tapan S, Ercin CN, Acikel C, Karslioglu Y, Bagci S.
    Ann Hepatol; 2013 Feb; 12(4):548-55. PubMed ID: 23813132
    [Abstract] [Full Text] [Related]

  • 5. Adipokines and cytokines in non-alcoholic fatty liver disease.
    Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM.
    Aliment Pharmacol Ther; 2008 Mar 01; 27(5):412-21. PubMed ID: 18081738
    [Abstract] [Full Text] [Related]

  • 6. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).
    Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N, Goodman Z, Chandhoke V, Baranova A.
    Obes Surg; 2008 Nov 01; 18(11):1430-7. PubMed ID: 18500507
    [Abstract] [Full Text] [Related]

  • 7. A Simple Index for Nonalcoholic Steatohepatitis-HUFA-Based on Routinely Performed Blood Tests.
    Culafic M, Vezmar Kovacevic S, Dopsaj V, Stulic M, Vlaisavljevic Z, Miljkovic B, Culafic D.
    Medicina (Kaunas); 2019 Jun 03; 55(6):. PubMed ID: 31163711
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis.
    El Bassat H, Ziada DH, Hasby EA, Nagy H, Abo Ryia MH.
    Arab J Gastroenterol; 2014 Mar 03; 15(1):6-11. PubMed ID: 24630506
    [Abstract] [Full Text] [Related]

  • 10. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease.
    Shipovskaya AA, Dudanova OP, Kurbatova IV.
    Ter Arkh; 2018 Aug 27; 90(8):63-68. PubMed ID: 30701940
    [Abstract] [Full Text] [Related]

  • 11. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
    Arab JP, Hernández-Rocha C, Morales C, Vargas JI, Solís N, Pizarro M, Robles C, Sandoval D, Ponthus S, Benítez C, Barrera F, Soza A, Riquelme A, Arrese M.
    Gastroenterol Hepatol; 2017 Aug 27; 40(6):388-394. PubMed ID: 28359548
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients.
    Koehler E, Swain J, Sanderson S, Krishnan A, Watt K, Charlton M.
    Liver Int; 2012 Feb 27; 32(2):279-86. PubMed ID: 22098614
    [Abstract] [Full Text] [Related]

  • 13. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
    Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J.
    Hepatology; 2004 Jul 27; 40(1):46-54. PubMed ID: 15239085
    [Abstract] [Full Text] [Related]

  • 14. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.
    Polyzos SA, Kountouras J, Papatheodorou A, Patsiaoura K, Katsiki E, Zafeiriadou E, Zavos C, Anastasiadou K, Terpos E.
    Metabolism; 2013 Jan 27; 62(1):121-6. PubMed ID: 22841522
    [Abstract] [Full Text] [Related]

  • 15. Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease.
    Kim YS, Jung ES, Hur W, Bae SH, Choi JY, Song MJ, Kim CW, Jo SH, Lee CD, Lee YS, Choi SW, Yang JM, Jang JW, Kim SG, Jung SW, Kim HK, Chae HB, Yoon SK.
    Clin Mol Hepatol; 2013 Jun 27; 19(2):120-30. PubMed ID: 23837136
    [Abstract] [Full Text] [Related]

  • 16. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
    Boga S, Koksal AR, Alkim H, Yilmaz Ozguven MB, Bayram M, Ergun M, Sisman G, Tekin Neijmann S, Alkim C.
    Metab Syndr Relat Disord; 2015 Nov 27; 13(9):393-9. PubMed ID: 26367098
    [Abstract] [Full Text] [Related]

  • 17. FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian Patients.
    Mohammed MA, Omar NM, Mohammed SA, Amin AM, Gad DF.
    Pak J Biol Sci; 2019 Jan 27; 22(10):457-466. PubMed ID: 31930835
    [Abstract] [Full Text] [Related]

  • 18. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis.
    Musso G, Gambino R, Biroli G, Carello M, Fagà E, Pacini G, De Michieli F, Cassader M, Durazzo M, Rizzetto M, Pagano G.
    Am J Gastroenterol; 2005 Nov 27; 100(11):2438-46. PubMed ID: 16279898
    [Abstract] [Full Text] [Related]

  • 19. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
    Pirvulescu I, Gheorghe L, Csiki I, Becheanu G, Dumbravă M, Fica S, Martin S, Sarbu A, Gheorghe C, Diculescu M, Copăescu C.
    Chirurgia (Bucur); 2012 Nov 27; 107(6):772-9. PubMed ID: 23294957
    [Abstract] [Full Text] [Related]

  • 20. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.
    Kashyap SR, Diab DL, Baker AR, Yerian L, Bajaj H, Gray-McGuire C, Schauer PR, Gupta M, Feldstein AE, Hazen SL, Stein CM.
    Obesity (Silver Spring); 2009 Sep 27; 17(9):1696-701. PubMed ID: 19360015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.